AB2 Bio Completes Enrolment in Pivotal Phase 3 Trial of
Topline pivotal Phase 3 results expected during second half of 2023Potential new treatment option in ultra-rare,
Globe Newswire7-03-2023, 15:05
NEWLY ELECTED 2023-25 OECTA PROVINCIAL EXECUTIVE 14-03-2023, 01:15